WuXi NextCODE Revenue and Competitors
Estimated Revenue & Valuation
- WuXi NextCODE's estimated annual revenue is currently $33.3M per year.
- WuXi NextCODE received $200.0M in venture funding in November 2018. 0
- WuXi NextCODE's total funding is $15M.
Employee Data
- 00
WuXi NextCODE's People
Name | Title | Email/Phone |
---|---|---|
1 | CFO | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Chief Strategy Officer Scientific/Medical | Reveal Email/Phone |
4 | Chief Technology Officer | Reveal Email/Phone |
5 | Chief Informatics Officer | Reveal Email/Phone |
6 | Clinical Genetics | Reveal Email/Phone |
7 | Statistical Sciences | Reveal Email/Phone |
8 | Oncology | Reveal Email/Phone |
WuXi NextCODE Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is WuXi NextCODE?
WuXi NextCODE is a global biotechnology company harnessing genomic big data to propel drug discovery, clinical diagnoses, population health, and precision medicine. We are the pioneers of the biggest dataset in the world. We've crafted a common language to harmonize all types of genomic data and unlock insights at unprecedented speed and scale. Our comprehensive platform has been used by world-class hospitals to deliver over 12K diagnoses to rare disease patients. We serve twelve out of the world's top fifteen pharmaceutical companies. We are the platform of choice for the world's largest population projects. WuXi NextCODE offers genomic data solutions, from sample to answer. Partner with us from end-to-end, or choose from a suite of solutions spanning sequencing, storage, analysis, and reports. In addition to our industry solutions, we provide consumer products in China for wellness, reproductive health, and rare disease diagnostics.
keywords:N/A$15M
Total Funding
N/A
Number of Employees
$33.3M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
WuXi NextCODE News
... Fisher Scientific, Agilent Technologies, Illumina Inc, QIAGEN, Partek, BGI, Waters Corporation, Sophia Genetics, Wuxi NextCODE, Eurofins Scientific.
... LLC, Encrypgen Incorporated, Digital DNAtix Ltd, Longenesis Ltd, WuXi Nextcode Genomics, and Shivom Ventures Limited, among others.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $64.9M | 0 | N/A | $751.3M |
#2 | $12.9M | 0 | N/A | $163M |
#3 | $9.8M | 0 | N/A | $39M |
#4 | $4.8M | 0 | N/A | N/A |
#5 | $4.6M | 0 | N/A | $38M |
WuXi NextCODE Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2013-10-24 | $15.0M | A | Polaris Partners | Article |
2017-05-02 | $75.0M | B | Temasek | Article |
2017-09-08 | $240.0M | B | Sequoia China | Article |
2018-11-28 | $200.0M | C | Ireland Strategic Investment Fund | Article |